https://charts.traderzeitung.de/phases/US8684591089
string(1464) "{"isin":"US8684591089","name":"Supernus Pharmaceuticals Inc","stock_id_xnas":7875055,"stock_id_xnys":null,"generated_at":"2026-07-11 05:04:00","days":[{"date":"2026-07-08","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":47.55,"close_at":"2026-07-08 15:29:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":50.44,"close_at":"2026-07-08 21:59:00","complete":true,"perf_pct":6.0778},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-09","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":50.9,"close_at":"2026-07-09 12:39:00","complete":true,"perf_pct":0.912},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":48.76,"close_at":"2026-07-09 21:59:00","complete":true,"perf_pct":-4.2043},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-10","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":49.24,"close_at":"2026-07-10 15:29:00","complete":true,"perf_pct":0.9844},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":48.47,"close_at":"2026-07-10 21:59:00","complete":true,"perf_pct":-1.5638},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Supernus Pharmaceuticals Aktie News & Nachrichten

Supernus Pharmaceuticals Aktie News & Nachrichten

[WKN: A1JX3U | Symbol: SUPN]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
Supernus Pharmaceuticals Chart

Pivotal-Point Nachverfolgung Supernus Pharmaceuticals (SUPN): Kursziel-Explosion nach Piper Sandler-Upgrade – Parkinson-Medikament Onapgo als neuer Umsatz-Star!

Supernus Pharmaceuticals ist ein auf die Biopharmazie spezialisiertes Unternehmen, das sich auf die Entwicklung...

Pivotal-Point Nachverfolgung Supernus Pharmaceuticals (SUPN): Kursziel-Explosion nach Piper Sandler-Upgrade – Parkinson-Medikament Onapgo als neuer Umsatz-Star!

Supernus Pharmaceuticals ist ein biopharmazeutisches Unternehmen aus den USA, das sich auf die Entwicklung...

TOP-5-Kursziele der Analysten am 09.10.25

HelloFresh [DE000A161408] UBS nimmt Hochstufung von "Neutral" auf "Buy" vor und erhöht das Kursziel...

  • 1